ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $275,000 | -57.3% | 45,651 | -74.5% | 0.00% | – |
| Q3 2019 | $644,000 | +2.9% | 179,274 | -23.5% | 0.00% | – |
| Q2 2019 | $626,000 | -57.6% | 234,449 | -53.1% | 0.00% | -100.0% |
| Q1 2019 | $1,477,000 | +249.2% | 499,420 | +87.1% | 0.00% | – |
| Q4 2018 | $423,000 | -92.1% | 266,931 | -81.7% | 0.00% | -100.0% |
| Q3 2018 | $5,362,000 | -52.4% | 1,457,770 | -63.4% | 0.00% | -33.3% |
| Q2 2018 | $11,259,000 | +61.0% | 3,978,914 | +111.1% | 0.00% | 0.0% |
| Q1 2018 | $6,992,000 | -5.4% | 1,885,235 | -26.5% | 0.00% | -40.0% |
| Q4 2017 | $7,388,000 | -1.2% | 2,566,018 | +54.1% | 0.01% | 0.0% |
| Q3 2017 | $7,474,000 | +24.7% | 1,665,159 | +27.5% | 0.01% | +25.0% |
| Q2 2017 | $5,992,000 | -1.9% | 1,305,900 | -10.0% | 0.00% | -20.0% |
| Q1 2017 | $6,109,000 | -17.4% | 1,451,693 | -19.0% | 0.01% | -16.7% |
| Q4 2016 | $7,396,000 | -48.3% | 1,791,322 | +1.5% | 0.01% | -40.0% |
| Q3 2016 | $14,297,000 | +23.2% | 1,765,275 | +18.7% | 0.01% | +25.0% |
| Q2 2016 | $11,600,000 | +10.0% | 1,487,623 | +8.8% | 0.01% | 0.0% |
| Q1 2016 | $10,550,000 | -31.0% | 1,366,854 | -3.6% | 0.01% | -27.3% |
| Q4 2015 | $15,288,000 | +212.8% | 1,417,274 | +100.3% | 0.01% | +175.0% |
| Q3 2015 | $4,887,000 | -10.1% | 707,551 | +15.2% | 0.00% | +33.3% |
| Q2 2015 | $5,438,000 | -39.0% | 614,168 | -32.1% | 0.00% | -50.0% |
| Q1 2015 | $8,910,000 | +70.0% | 903,974 | +111.1% | 0.01% | +100.0% |
| Q4 2014 | $5,242,000 | +51.2% | 428,169 | +23.1% | 0.00% | +50.0% |
| Q3 2014 | $3,467,000 | +99.7% | 347,685 | +51.5% | 0.00% | +100.0% |
| Q2 2014 | $1,736,000 | +1.7% | 229,568 | -55.8% | 0.00% | 0.0% |
| Q1 2014 | $1,707,000 | +62.7% | 519,152 | +62.0% | 0.00% | 0.0% |
| Q4 2013 | $1,049,000 | +44.7% | 320,515 | +31.1% | 0.00% | 0.0% |
| Q3 2013 | $725,000 | – | 244,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |